Bloomberg -- Roche Holding AG’s plan to reduce costs may cast off drug discovery projects, providing a boost to Switzerland’s ailing biotechnology industry and venture capitalists seeking to create health-care companies.
Bloomberg -- Roche Holding AG’s plan to reduce costs may cast off drug discovery projects, providing a boost to Switzerland’s ailing biotechnology industry and venture capitalists seeking to create health-care companies.
